Company Overview

We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

Our secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with physician/medical providers to administer intravenous infusions of ketamine.